Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients

2026-06-03

Pier Giorgio Cojutti *

Alice Toschi

Zeno Pasquini

Stefania Paolini

Enrico Maffini

Francesca Bonifazi

Pier Luigi Zinzani

Maddalena Giannella

Pierluigi Viale

Federico Pea

DOI：10.1093/jac/dkag183

Original

Original request for help

Save

Abstract

En 中文

Onco-haematological patients with febrile neutropenia are at high risk of severe infections caused by multidrug-resistant pathogens. Continuous infusion (CI) of beta-lactams may improve pharmacokinetic/pharmacodynamic (PK/PD) target attainment, yet evidence in this population remains limited.

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients

Abstract

Journal

Organization

Cited Papers

Citing Papers